Sigma Labs Announces First Quarter Financial Results

SANTA FE, N.M., May 14, 2015 (GLOBE NEWSWIRE) -- Sigma Labs, Inc. (OTCQB:SGLB) ("Sigma Labs" or the "Company"), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing ("AM") and other advanced manufacturing technologies, today announced financial results for the three months ended March 31, 2015.

Recent Highlights

  • Booked revenue of approximately $0.2 million for the quarter, versus approximately $0.1 million in the first quarter of 2014
  • Announced that Honeywell placed a commercial order for Sigma Labs' PrintRite3D® system. The Company will deliver and install its PrintRite3D® SENSORPAK™ hardware and INSPECT™ software at Honeywell's development facility in Phoenix; in addition, the purchase contract includes Sigma Labs' groundbreaking DEFORM™ software, which will be provided when ready for release in the near future
  • The Company hosted an open house event on April 14, 2015 for its EOS M290 additive manufacturing metal printer enhanced with Sigma Labs' PrintRite3D® software. Approximately 60 individuals attended the event, which included a live demonstration of 3D printing. Sigma Labs is in discussions with potential clients from North America and Europe, as well as China
  • Sigma Labs also announced that it has become a Silver member of America Makes, the National Additive Manufacturing Innovation Institute
  • The Company remains on track for significant growth in 2015

"Sigma Labs made further progress this quarter introducing its products and services to potential customers, showcasing its technology, and positioning the Company for future success," said Mark Cola, President and CEO of Sigma Labs. "We continued to actively demonstrate our proprietary PrintRite3D® software to numerous organizations and have a large pipeline of opportunities which should lead to additional awards in the weeks and months to come. It is a very busy time for the Company, and we are focused on top line growth and to solidify our unique position in the industry as it rapidly evolves. At the same time, we are very encouraged by initial interest in our contract manufacturing business, which has already received some small awards and generated inquiries both here and abroad. Overall, we remain committed to expanding the Company's base of business and improving bottom line results, and we are optimistic that Sigma Labs will benefit from accelerating demand in the quarters to come."

2015 First Quarter Financial Results

Service revenue for the three months ended March 31, 2015 was approximately $0.2 million, versus approximately $0.1 million for the same period in 2014. The Company reported a net loss for the three months ended March 31, 2015 of approximately $0.4 million, or $(0.00) per diluted share, versus a loss of approximately $0.5 million, or $(0.00) per diluted share, for the first quarter of 2014.

Investor Conference Call

The Company will host a conference call to discuss its 2015 first quarter financial results today, May 14, 2015, at 11:00 a.m. Eastern Time. To participate in the call, please dial toll free 1-888-243-4451, or 1-412-542-4135, approximately five minutes before the conference call time stated. A live webcast of the call can also be accessed on the Sigma Labs website at A recording will be available on the Company's website upon completion of the call.

About Sigma Labs, Inc.

Sigma Labs, Inc., through its wholly-owned subsidiary B6 Sigma, Inc., develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies. For more information please visit us at

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.

Sigma Labs, Inc. and Subsidiary
Unaudited Condensed Consolidated Statements of Operations
Three Months Ended March 31, 2015 and 2014
Three Months Ended Three Months Ended
March 31, 2015 March 31, 2014
Services $ 185,686 $ 114,829
Total Revenue 185,686 114,829
GROSS PROFIT 160,819 58,940
Other General and Administration 267,703 249,543
Payroll Expense 72,660 251,945
Non-cash Stock Compensation 122,750 25,200
Research and Development 70,147 --
Total Expenses 533,260 526,688
Interest Income 560 842
Interest Expense -- --
Total Other Income (Expense) 560 842
Current Income Tax Expense -- --
Deferred Income Tax Expense -- --
Net Income (Loss) $ (371,881) $ (466,906)
Loss per Common Share - Basic and Diluted $ (0.00) $ (0.00)
Weighted Average Number of Shares Outstanding - Basic and Diluted 620,621,984 598,842,450
Sigma Labs, Inc. and Subsidiary
Condensed Consolidated Balance Sheets
March 31, 2015 and December 31, 2014
March 31, 2015 December 31, 2014
(Unaudited) (Audited)
Current Assets
Cash $ 2,489,660 $ 2,962,069
Accounts Receivable, net 164,571 117,726
Inventory 62,444 56,175
Prepaid Assets 21,529 29,986
Total Current Assets 2,738,204 3,165,956
Other Assets
Property and Equipment, net 769,979 803,027
Deferred Stock Offering Costs 95,511 95,511
Intangible Assets, net 96,617 95,847
Total Other Assets 962,107 994,385
TOTAL ASSETS $ 3,700,311 $ 4,160,341
Current Liabilities
Accounts Payable $ 97,289 $ 309,698
Accrued Expenses 46,162 44,652
Total Current Liabilities 143,451 354,350
TOTAL LIABILITIES 143,451 354,350
Stockholders' Equity
Preferred Stock, $0.001 par; 10,000,000 shares authorized;
None issued and outstanding -- --
Common Stock, $0.001 par; 750,000,000 shares authorized;
623,344,835 issued and 614,767,005
outstanding at March 31, 2015 and
619,741,061 issued and 612,741,061
outstanding at December 31, 2014 623,345 619,741
Additional Paid-In Capital 9,985,684 9,798,288
Less Deferred Compensation
8,577,830 and 7,000,000 common shares, respectively (812,450) (744,200)
Retained Earnings (Deficit) (6,239,719) (5,867,838)
Total Stockholders' Equity 3,556,860 3,805,991

CONTACT: Investor Relations Contact: Chris Witty 646-438-9385Source:Sigma Labs, Inc.